1. Validation of the APRI+ALBI smart phone application for preoperative risk assessment after liver resection in a routine clinical setting. (2021) Authors: Pereyra, D.; Santol, J.; Ammon, D.; Ortmayr, G.; Jonas, J.P.; Koeditz, C.; Rumpf, B.; Gruenberger, T.; Starlinger, Johannes; Smoot, R.L.; Cleary, S.P.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Von Willebrand factor antigen as a versatile preoperative marker in patients undergoing liver resection for hepatocellular carcinoma. (2021) Authors: Pereyra, D.; Mandorfer, M.; Santol, J.; Koeditz, C.; Ortmayr, G.; Schuetz, C.; Rumpf, B.; Laengle, J.; Jonas, P.; Tamandl, D.; Gruenberger, T.; Reiberger, T.; Cleary, S.P.; Starlinger, P. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Von Willebrand Factor Antigen Facilitates Long Term Risk Stratification In Patients Undergoing Liver Resection. (2020) Authors: Pereyra, D.; Koeditz, C.; Ortmayr, G.; Schuetz, C.; Santol, J.; Rumpf, B.; Najarnia, S.; Jonas, J.P.; Gruenberger, T.; Reiberger, T.; Starlinger, P. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗